These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35644719)

  • 21. Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands.
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2022 Feb; 126(2):122-128. PubMed ID: 35000802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptance of selective contracting: the role of trust in the health insurer.
    Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators.
    Portrait FR; van der Galiën O; Van den Berg B
    Health Econ; 2016 Apr; 25(4):408-23. PubMed ID: 25702821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competition policy for health care provision in the Netherlands.
    Schut FT; Varkevisser M
    Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No exit? The effect of health status on dissatisfaction and disenrollment from health plans.
    Schlesinger M; Druss B; Thomas T
    Health Serv Res; 1999 Jun; 34(2):547-76. PubMed ID: 10357290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the reform of the Dutch healthcare into managed competition: Results of a Delphi study among experts.
    de Vries H; Vahl J; Muris J; Evers S; van der Horst H; Cheung KL
    Health Policy; 2021 Jan; 125(1):27-33. PubMed ID: 33189409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managed care plans: characteristics, growth, and premium performance.
    Miller RH; Luft HS
    Annu Rev Public Health; 1994; 15():437-59. PubMed ID: 8054094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restrictions on provider access in health plans and socioeconomic status.
    Deb P; Trivedi PK
    Health Serv Res; 2006 Oct; 41(5):1821-46. PubMed ID: 16987304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health insurance plans and immunization: assessment of practices and policies, 2005-2008.
    Hunsaker J; Veselovskiy G; Gazmararian JA
    Pediatrics; 2009 Dec; 124 Suppl 5():S532-9. PubMed ID: 19948585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare transition managers make market exits easier for insurers.
    Resnick LR
    Healthc Financ Manage; 1999 Oct; 53(10):39-41. PubMed ID: 11066665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free choice of healthcare providers in the Netherlands is both a goal in itself and a precondition: modelling the policy assumptions underlying the promotion of patient choice through documentary analysis and interviews.
    Victoor A; Friele RD; Delnoij DM; Rademakers JJ
    BMC Health Serv Res; 2012 Dec; 12():441. PubMed ID: 23206601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consumer choice of social health insurance in managed competition.
    Kerssens JJ; Groenewegen PP
    Health Expect; 2003 Dec; 6(4):312-22. PubMed ID: 15040793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of the State Children's Health Insurance Program (SCHIP) in New York: changing program features and enrollee characteristics.
    Dick AW; Klein JD; Shone LP; Zwanziger J; Yu H; Szilagyi PG
    Pediatrics; 2003 Dec; 112(6 Pt 2):e542. PubMed ID: 14654676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How can community participation strengthen a health insurance system? The case of health insurer's user associations in Colombia.
    Bolivar-Vargas M; Alfonso-Sierra E; Bonilla J; Herrera M; Rodriguez H; Villar-Uribe M; Scott K; Mathauer I
    BMJ Glob Health; 2022 Sep; 7(Suppl 6):. PubMed ID: 36379588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reimbursing insurance carriers: the case of 'MUFACE' in the Spanish health care system.
    Pellisé L
    Health Econ; 1994; 3(4):243-53. PubMed ID: 7994324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Building a competitive insurance system: Switzerland's strategy for managed-care healthcare.
    Zweifel P
    Pharmacoeconomics; 2006 Dec; 24 Suppl 2():111-9. PubMed ID: 23389494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terminating Cost-Sharing Reduction Subsidy Payments: The Impact Of Marketplace Zero-Dollar Premium Plans On Enrollment.
    Drake C; Anderson DM
    Health Aff (Millwood); 2020 Jan; 39(1):41-49. PubMed ID: 31905063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stuck in the middle?: A perspective on ongoing pro-competitive reforms in Dutch mental health care.
    Westra D; Wilbers G; Angeli F
    Health Policy; 2016 Apr; 120(4):345-9. PubMed ID: 26994866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.